跳至主要内容
临床试验/NCT05603416
NCT05603416进行中(未招募)不适用

Investigation of Benegut® on Immediate GI Discomfort Relief Caused by Acute Overfeeding in Healthy Subjects- a Randomized, Placebo-controlled Cross-over Study

Vital Solutions GmbH2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
2
主要终点
Overall gastrointestinal discomfort assessed with a visual analogue scale (VAS)

研究概览

简要总结

To determine the relief of GI discomfort after overfeeding with a high caloric meal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers without clinical diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility.
  • Age ≥ 25 and ≤ 70 years
  • BMI: 19-30 kg/m2
  • Overall GI discomfort after high caloric meal of at least 5 on the VAS scale
  • Male or female
  • Written consent to participate in the study
  • Subject is able and willing to follow the study protocol procedures
  • If applicable, stable intake of chronic medication of at least 3 months

排除标准

  • Criteria for inclusion:
  • Healthy volunteers without clinical diagnosed diseases with relevant effect on the gastrointestinal system or on visceral motility.
  • Age ≥ 25 and ≤ 70 years
  • BMI: 19-30 kg/m2
  • Overall GI discomfort after high caloric meal of at least 5 on the VAS scale
  • Male or female
  • Written consent to participate in the study
  • Subject is able and willing to follow the study protocol procedures
  • If applicable, stable intake of chronic medication of at least 3 months
  • Criteria for exclusion:
  • Relevant history, presence of any medical disorder (e.g. cancer, severe liver disease, severe renal disease, severe cardiovascular disease)
  • Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs or use of PPI (proton pump inhibitors) or other digestive auxiliaries potentially interfering with this study at screening
  • Intake of antibiotics in the last 4 weeks
  • Women suffering from distinct PMS symptoms
  • Acute gastrointestinal diseases including diarrhea and/or vomiting within the last 2 weeks
  • Change of dietary habits within the 4 weeks prior to screening (for instance start of a diet high in fibers)
  • Vegetarian or vegan nutrition style
  • Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject.
  • Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study.
  • Participation in another clinical intervention study within the last 4 weeks and concurrent participation in another intervention clinical study
  • Subject who according to the study staff's opinion is not suitable for participation in the study

结局指标

主要结局

Overall gastrointestinal discomfort assessed with a visual analogue scale (VAS)

时间窗: Chance over time after single dosage (pre, 0 minutes and after 5 minutes,15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes)

In the current study, GI discomfort, following a high caloric meal, will be assessed with a visual analogue scale (VAS) before and after meal at defined timepoints.

次要结局

  • Follow up assessment of gastrointestinal symptoms on a 6-point Likert scale(Day 1 immediately prior going to bed, day 2 immediately after wake up)
  • Monitoring of related adverse events(up to 14 hours after intake)
  • Assessment of gastrointestinal symptoms on a 6-point Likert scale(Chance over time after single dosage (pre, 0 minutes and after 5 minutes,15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes))

研究者

发起方
Vital Solutions GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Investigation of Benegut® on Immediate GI Discomfort... | 临床试验